SLC2A1 and epilepsy with myoclonic atonic seizures: Based on recent reports describing SLC2A1 mutations in patients with myoclonic astatic epilepsy (MAE), early onset absence epilepsy (EOAE), and genetic generalized epilepsies (GGEs), they aimed to replicate these findings in a cohort of European patients.